Lavender Sky Health vs MEDVi vs Yucca Health (2026)

On tirzepatide, the order is Yucca Health↗ ($258) → Lavender Sky Health↗ ($352) → MEDVi↗ ($399) — gaps of $94 and then $47 a month, a $1,692 spread across a year between first and last. All-in figures, 10 mg basis, captured 2026-08-09.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

§ Each record, condensed

The three records, one screen

Yucca Health: the record, condensed

On tirzepatide, the number that matters at Yucca Health is $258 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at Yucca Health is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $258 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #2 of 17 in the verified tirzepatide index — $43/month above the floor (NexLife↗, $215) — and sits $191 under the brand benchmark (Zepbound (LillyDirect↗), $449 at maintenance). Annualized, a monthly-billed year here runs $3,096.

Yucca Health’s semaglutide program bills $146 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $146 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

To place the number: #2 of 20 verified programs, with the floor $13/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare↗)) sits at $349, so the compounded case here is worth $203 a month. A year at this figure: $1,752 monthly-billed.

Operationally at Yucca Health: shipping included; commitment 6-month term; cancellation 6-month term applies; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Yucca Health page · visit Yucca Health ↗

Lavender Sky Health: the record, condensed

On tirzepatide, the number that matters at Lavender Sky Health is $352 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. The structure is tiered: the advertised entry point is $200, but the maintenance figure — the one a full year is actually billed at — is $352. That $152 gap between the ad and the anniversary is the single most important line in this record.

Inside that $352 sits a mandatory $25-a-month membership. We fold it in automatically — the medication-only figure the marketing may lead with is $327, and it is not a price anyone can actually pay, because the membership cannot be declined.

Context for that figure: it ranks #12 of 17 in the verified tirzepatide index — $137/month above the floor (NexLife, $215) — and sits $97 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,224.

Start with the load-bearing figure: $174 a month, all-in, is what Lavender Sky Health charges for semaglutide at the 2.4 mg basis. The figure is quoted at maintenance without a separate teaser tier, which keeps the arithmetic honest by default.

A required $25/month membership is part of the deal, and part of the figure above: $149 of medication plus $25 of platform equals the $174 that leaves your account. Judge the membership by what it includes, but compare on the total.

To place the number: #6 of 20 verified programs, with the floor $41/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $175 a month. A year at this figure: $2,088 monthly-billed.

Operationally at Lavender Sky Health: shipping included; commitment monthly plan fee recurs; cancellation plan fee recurs until cancelled; pharmacy not publicly named — ask in writing before paying; states: not published; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the Lavender Sky Health page · visit Lavender Sky Health ↗

MEDVi: the record, condensed

MEDVi’s tirzepatide program bills $399 a month once every mandatory fee is counted, measured at the 10 mg maintenance basis. The price is dose-flat: the standard titration ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $399 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

To place the number: #14 of 17 verified programs, with the floor $184/month below at NexLife ($215); the approved-product yardstick (Zepbound (LillyDirect)) sits at $449, so the compounded case here is worth $50 a month. A year at this figure: $4,788 monthly-billed.

MEDVi’s semaglutide program bills $299 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.

Context for that figure: it ranks #18 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗

§ The three-way read

Prices, gaps, and what sits inside them

Yucca Health holds the low ground at $258 — dose-flat, so that figure is a ceiling with no membership attached. Lavender Sky Health follows at $352 (+$94/mo, $1,128/yr), membership included. MEDVi tops the trio at $399 (+$141/mo over the leader, $1,692/yr) — note its record’s watch-out below.

The semaglutide picture reshuffles nothing: Yucca Health $146 → Lavender Sky Health $174 → MEDVi $299 — a reminder that molecule choice and provider choice are separate decisions, priced separately in the semaglutide index.

§ Category winners among the three

Who wins what

Cheapest month-to-month: Yucca Health ($258); cheapest 12-month path: Yucca Health ($3,096); simplest billing (no membership): Yucca Health and MEDVi; dose-flat structure: Yucca Health and MEDVi; cheapest semaglutide of the three: Yucca Health ($146).

Every winner above is a computation, not a placement; the pairwise pages carry the full duels: Yucca Health vs Lavender Sky Health (record · record) · Yucca Health vs MEDVi · Lavender Sky Health vs MEDVi (record · record).

§ Structure, three ways

Everything besides the three prices

Memberships: Yucca Health none; Lavender Sky Health $25/mo (inside its figure); MEDVi none. Structures: Yucca Health dose-flat; Lavender Sky Health step/tiered; MEDVi dose-flat. Pharmacies: Yucca Health not named; Lavender Sky Health not named; MEDVi not named. States: Yucca Health — not published; Lavender Sky Health — not published; MEDVi — priced differently in CA/NC on some plans. Exit terms: Yucca Health — 6-month term applies; Lavender Sky Health — plan fee recurs until cancelled; MEDVi — 12-month plan applies to lowest rate.

The census reading: where all three match on an axis, that axis cannot break the tie and the price column rules; where they split — a membership here, an unnamed pharmacy there — the split is usually worth more than a small price gap, because structure is what you live with after month one. Evidence for all three: Yucca Health source-verified (2026-08-05); Lavender Sky Health source-verified (2026-08-05); MEDVi source-verified (2026-08-05).

The trio on semaglutide, across time

3 mo: Yucca Health $438 vs Lavender Sky Health $522 vs MEDVi $897 6 mo: Yucca Health $876 vs Lavender Sky Health $1,044 vs MEDVi $1,794 12 mo: Yucca Health $1,752 vs Lavender Sky Health $2,088 vs MEDVi $3,588 — monthly-billed totals; prepaid paths where published appear on each provider page.

§ Twelve and twenty-four months

The trio, annualized

Yucca Health: $3,096/yr monthly-billed; Lavender Sky Health: $4,224/yr monthly-billed; MEDVi: $4,788/yr monthly-billed. Across two years at monthly billing the first-to-last spread widens to $3,384 — the horizon at which structure (prepaid ladders, flat pricing, membership drag) matters more than the sticker.

The elimination read

Work it as eliminations rather than a beauty contest. MEDVi enters owing an explanation: $141/month above Yucca Health compounds to $1,692 a year — real therapy-months of money — so its record has to name what the premium buys (structure the cheaper two lack) or it exits first. Lavender Sky Health survives the first cut only to face the harder question — whether its $25/mo membership bundles services the floor does not is worth $94 a month to you — because a middle option that cannot answer it is just the expensive option with better camouflage. Yucca Health is what remains: the arithmetic answer at $258, dethroned only by a state gap, a structural need, or a prescriber’s judgment — the three things this page deliberately cannot decide.

The same trio on best published rate: Yucca Health $258 → Lavender Sky Health $352 → MEDVi $399 — all three price month-to-month only at capture. Short-horizon totals, monthly-billed: 3 months — Yucca Health $774, Lavender Sky Health $1,056, MEDVi $1,197; 6 months — Yucca Health $1,548, Lavender Sky Health $2,112, MEDVi $2,394. 0 of the three publish a prepaid path below their own monthly billing; the twelve- and twenty-four-month table below carries those, labeled.

Grade the three records before trusting the three prices. On the five-point disclosure checklist (price, pharmacy, states, cancellation, source-verification): Yucca Health 4/5 · Lavender Sky Health 4/5 · MEDVi 4/5. Even scores across the board — so this particular trio really is a pure price-and-structure decision. No axis splits them, a small collective credit. Every score is a computation from the dataset, contestable at the corrections desk like any other figure.

The three-way verdict compresses cleanly: Yucca Health is the default on arithmetic; Lavender Sky Health earns the middle only where its structure (membership services) solves something the floor does not; and MEDVi’s $141/month premium over the leader — $1,692 a year, roughly 6.6 extra months of therapy at the floor rate — needs a named justification from its record, not a vibe. Insurance coverage, where it exists, outranks all three.